Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • spudybudy
    Junior Member
    • May 2009
    • 3

    Bioanalyser traces + QC postPCR. ChIPseq Illumina protocol

    Hi everyone.
    I have been trying to get ChIPseq libraries. I started with 10ng as suggested by Illumina and got a Bioanalyser trace. Problems: the trace is actually two quite-fused peaks. The first at around 165bp and the second at around 224bp (I cut the gel from 125-150bp to 300bp).
    Is this normal?
    Another question would be if anyone does a QC after the protocol's PCR. imagine you start with the INPUT sample (pre-immunoprecipitated DNA. Your ChIP background control, basically) which is normal fragmented genomic DNA. Before library preparation, you have the same amount for all genomic locations (as seen on RT-PCR). But after library PCR, there is a quite strong bias for some regions compared to others. Is this normal? do you do this QC step or go direcly into sequencing if the library looks fine on the Bioanalyser?
    Cheers everyone in advance!
  • Susanne
    Member
    • Aug 2009
    • 33

    #2
    Did you try to run the IP-ed material (on the Bioanalyzer) before sample prep.? This may give you a clue if the size distribution looked like this before adding the adapters.
    Sorry, not the complete solution, but maybe it give a hint...

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Working...